CONCLUSIONS CONFLICTS OF INTEREST In the last 5 years Adie Viljoen has received lecture honoraria and/or travel support and/or conducts clinical trials funded by: Amarin, Amgen, Astra Zeneca, Boehringer Ingleheim, Daiichi-Sankyo, Lilly, Menarini, NewAmsterdam, Novartis, Novo Nordisk, Pfizer, Regeneron, Sanofi, Takeda, and Tosoh
It is natural to wonder if moving to the next strength is the right move for your journey
This precision approach eliminates months of trial-and-error guessing
The action date for the decision on the oral semaglutide NDA is targeted for Q4 2025
You can get the sharps container from a pharmacy near you or order it from Novo Nordisk
40 Indeed, patients at later stages of HF may respond differently to therapy that improves outcomes in less severe disease states